Epigenetic changes of mesenchymal stem cells in three-dimensional (3D) spheroids

Journal of Cellular and Molecular Medicine

Volumn 18, Issue 10, 2014, Pages 2009-2019

  Guo, Ling ^a   Zhou, Ying ^a   Wang, Shan ^a   Wu, Yaojiong ^a  

^a TSINGHUA UNIVERSITY   (China)

Author keywords

3D culture; Histone acetylation; Mesenchymal stem cells; MiRNA; Multi potency

Indexed keywords

HISTONE; HOMEODOMAIN PROTEIN; MESSENGER RNA; NANOG PROTEIN, HUMAN; OCTAMER TRANSCRIPTION FACTOR 4; POU5F1 PROTEIN, HUMAN; SOX2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX;

ACETYLATION; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CYTOLOGY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC EPIGENESIS; GENETICS; HUMAN; MESENCHYMAL STROMA CELL; METABOLISM; MULTICELLULAR SPHEROID; PLACENTA; PREGNANCY; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; REGENERATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ACETYLATION; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; EPIGENESIS, GENETIC; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HISTONES; HOMEODOMAIN PROTEINS; HUMANS; MESENCHYMAL STROMAL CELLS; OCTAMER TRANSCRIPTION FACTOR-3; PLACENTA; PREGNANCY; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; REGENERATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SOXB1 TRANSCRIPTION FACTORS; SPHEROIDS, CELLULAR;

EID: 84908062340     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12336     Document Type: Article

References (38)

1. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science. 1997; 276: 71-4.
2. Horwitz EM. MSC: a coming of age in regenerative medicine. Cytotherapy. 2006; 8: 194-5.
3. Wu Y, Chen L, Scott PG, et al. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells. 2007; 25: 2648-59.
4. Chamberlain G, Fox J, Ashton B, et al. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells. 2007; 25: 2739-49.
5. Keating A. Mesenchymal stromal cells: new directions. Cell Stem Cell. 2012; 10: 709-16.
6. Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat RevImmunol. 2008; 8: 726-36.
7. Salem HK, Thiemermann C. Mesenchymal stromal cells: current understanding and clinical status. Stem Cells. 2010; 28: 585-96.
8. Liao L, Zhao RC. An overview of stem cell-based clinical trials in China. Stem Cells Dev. 2008; 17: 613-8.
9. Philippe B, Luc S, Valerie PB, et al. Culture and use of mesenchymal stromal cells in phase I and II clinical trials. Stem Cells Int. 2010; 2010: 503593.
10. Silva J, Smith A. Capturing pluripotency. Cell. 2008; 132: 532-6.
11. Han J, Mistriotis P, Lei P, et al. Nanog reverses the effects of organismal aging on mesenchymal stem cell proliferation and myogenic differentiation potential. Stem Cells. 2012; 30: 2746-59.
12. Yannarelli G, Pacienza N, Cuniberti L, et al. The potential role of epigenetics on multipotent cell differentiation capacity of mesenchymal stromal cells. Stem Cells. 2013; 31: 215-20.
13. Blasco MA. Telomeres and human disease: ageing, cancer and beyond. Nat Rev Genet. 2005; 6: 611-22.
14. Bao X, Wei J, Feng M, et al. Transplantation of human bone marrow-derived mesenchymal stem cells promotes behavioral recovery and endogenous neurogenesis after cerebral ischemia in rats. Brain Res. 2011; 1367: 103-13.
15. Breitbach M, Bostani T, Roell W, et al. Potential risks of bone marrow cell transplantation into infarcted hearts. Blood. 2007; 110: 1362-9.
16. Bartosh TJ, Ylostalo JH, Mohammadipoor A, et al. Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties. Proc Natl Acad Sci USA. 2010; 107: 13724-9.
17. Potapova IA, Gaudette GR, Brink PR, et al. Mesenchymal stem cells support migration, extracellular matrix invasion, proliferation, and survival of endothelial cells in vitro. Stem Cells. 2007; 25: 1761-8.
18. Lee EJ, Park SJ, Kang SK, et al. Spherical bullet formation via E-cadherin promotes therapeutic potency of mesenchymal stem cells derived from human umbilical cord blood for myocardial infarction. Mol Ther. 2012; 20: 1424-33.
19. Li Z, Liu C, Xie Z, et al. Epigenetic dysregulation in mesenchymal stem cell aging and spontaneous differentiation. PLoS ONE. 2011; 6: e20526.
20. Deng W, Obrocka M, Fischer I, et al. In vitro differentiation of human marrow stromal cells into early progenitors of neural cells by conditions that increase intracellular cyclic AMP. Biochem Biophys Res Commun. 2001; 282: 148-52.
21. Sauerzweig S, Munsch T, Lessmann V, et al. A population of serum deprivation-induced bone marrow stem cells (SD-BMSC) expresses marker typical for embryonic and neural stem cells. Exp Cell Res. 2009; 315: 50-66.
22. Nelson JD, Denisenko O, Bomsztyk K. Protocol for the fast chromatin immunoprecipitation (ChIP) method. Nat Protoc. 2006; 1: 179-85.
23. Kawasaki Y, Ino F, Mizutani Y, et al. High-performance computing service over the internet for intraoperative image processing. IEEE Trans Inf Technol Biomed. 2004; 8: 36-46.
24. Xu N, Papagiannakopoulos T, Pan G, et al. MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell. 2009; 137: 647-58.
25. Chen LH, Chiou GY, Chen YW, et al. MicroRNA and aging: a novel modulator in regulating the aging network. Ageing Res Rev. 2010; 9: S59-66.
26. Guo L, Zhao RC, Wu Y. The role of microRNAs in self-renewal and differentiation of mesenchymal stem cells. Exp Hematol. 2011; 39: 608-16.
27. Krampera M, Pasini A, Rigo A, et al. HB-EGF/HER-1 signaling in bone marrow mesenchymal stem cells: inducing cell expansion and reversibly preventing multilineage differentiation. Blood. 2005; 106: 59-66.
28. Wu Y, Zhao RC. The role of chemokines in mesenchymal stem cell homing to myocardium. Stem Cell Rev. 2012; 8: 243-50.
29. Teven CM, Liu X, Hu N, et al. Epigenetic regulation of mesenchymal stem cells: a focus on osteogenic and adipogenic differentiation. Stem Cells Int. 2011; 2011: 201371.
30. Cheung TH, Quach NL, Charville GW, et al. Maintenance of muscle stem-cell quiescence by microRNA-489. Nature. 2012; 482: 524-8.
31. Yannarelli G, Pacienza N, Cuniberti L, et al. The potential role of epigenetics on multipotent cell differentiation capacity of mesenchymal stromal cells. Stem Cells. 2013; 31: 215-20.
32. Greco SJ, Liu K, Rameshwar P. Functional similarities among genes regulated by Oct4 in human mesenchymal and embryonic stem cells. Stem Cells. 2007; 25: 3143-54.
33. Tsai CC, Chen CL, Liu HC, et al. Overexpression of hTERT increases stem-like properties and decreases spontaneous differentiation in human mesenchymal stem cell lines. J Biomed Sci. 2010; 17: 64.
34. Huang GS, Dai LG, Yen BL, et al. Spheroid formation of mesenchymal stem cells on chitosan and chitosan-hyaluronan membranes. Biomaterials. 2011; 32: 6929-45.
35. Tan J, Huang H, Huang W, et al. The genomic landscapes of histone H3-Lys9 modifications of gene promoter regions and expression profiles in human bone marrow mesenchymal stem cells. J Genet Genomics. 2008; 35: 585-93.
36. Yu JM, Wu X, Gimble JM, et al. Age-related changes in mesenchymal stem cells derived from rhesus macaque bone marrow. Aging Cell. 2011; 10: 66-79.
37. Lee RH, Pulin AA, Seo MJ, et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell. 2009; 5: 54-63.
38. Wang CC, Chen CH, Hwang SM, et al. Spherically symmetric mesenchymal stromal cell bodies inherent with endogenous extracellular matrices for cellular cardiomyoplasty. Stem Cells. 2009; 27: 724-32.